CN104432322A - Method for preparing fermented strawberry juice with therapeutic efficacy - Google Patents
Method for preparing fermented strawberry juice with therapeutic efficacy Download PDFInfo
- Publication number
- CN104432322A CN104432322A CN201410750887.6A CN201410750887A CN104432322A CN 104432322 A CN104432322 A CN 104432322A CN 201410750887 A CN201410750887 A CN 201410750887A CN 104432322 A CN104432322 A CN 104432322A
- Authority
- CN
- China
- Prior art keywords
- stereotyped
- dull
- strawberry juice
- pqq
- juice
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013948 strawberry juice Nutrition 0.000 title claims abstract description 118
- 238000000034 method Methods 0.000 title abstract description 10
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- 238000000855 fermentation Methods 0.000 claims abstract description 73
- 244000199866 Lactobacillus casei Species 0.000 claims abstract description 66
- 235000013958 Lactobacillus casei Nutrition 0.000 claims abstract description 64
- 229940017800 lactobacillus casei Drugs 0.000 claims abstract description 64
- 231100000350 mutagenesis Toxicity 0.000 claims abstract description 26
- 238000002703 mutagenesis Methods 0.000 claims abstract description 26
- 230000000694 effects Effects 0.000 claims abstract description 25
- 229930182817 methionine Natural products 0.000 claims abstract description 25
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims abstract description 23
- 229940086319 nattokinase Drugs 0.000 claims abstract description 21
- 108010073682 nattokinase Proteins 0.000 claims abstract description 21
- 238000012216 screening Methods 0.000 claims abstract description 17
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000002156 mixing Methods 0.000 claims abstract description 9
- 235000013557 nattō Nutrition 0.000 claims description 108
- 230000004151 fermentation Effects 0.000 claims description 71
- 241000894006 Bacteria Species 0.000 claims description 52
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 52
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 48
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 48
- 239000007787 solid Substances 0.000 claims description 42
- 230000001580 bacterial effect Effects 0.000 claims description 24
- 239000012530 fluid Substances 0.000 claims description 21
- 235000015097 nutrients Nutrition 0.000 claims description 21
- 238000002360 preparation method Methods 0.000 claims description 19
- 230000004913 activation Effects 0.000 claims description 17
- 125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 claims description 15
- 230000004907 flux Effects 0.000 claims description 13
- 230000004927 fusion Effects 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 10
- 239000000835 fiber Substances 0.000 claims description 9
- 231100000219 mutagenic Toxicity 0.000 claims description 9
- 230000003505 mutagenic effect Effects 0.000 claims description 9
- 238000001556 precipitation Methods 0.000 claims description 8
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 7
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 6
- 229950003499 fibrin Drugs 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 230000000007 visual effect Effects 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 3
- 241000220223 Fragaria Species 0.000 claims 1
- 230000008707 rearrangement Effects 0.000 abstract description 28
- 230000035772 mutation Effects 0.000 abstract description 24
- 239000000758 substrate Substances 0.000 abstract description 13
- 244000063299 Bacillus subtilis Species 0.000 abstract description 12
- 235000014469 Bacillus subtilis Nutrition 0.000 abstract description 12
- 230000003044 adaptive effect Effects 0.000 abstract description 12
- 238000005516 engineering process Methods 0.000 abstract description 6
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000007547 defect Effects 0.000 abstract description 2
- LOUPRKONTZGTKE-WZBLMQSHSA-N Quinine Chemical compound C([C@H]([C@H](C1)C=C)C2)C[N@@]1[C@@H]2[C@H](O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-WZBLMQSHSA-N 0.000 abstract 10
- ZIUYHTQZEPDUCZ-UHFFFAOYSA-N 7h-pyrrolo[2,3-h]quinoline Chemical compound C1=CN=C2C(C=CN3)=C3C=CC2=C1 ZIUYHTQZEPDUCZ-UHFFFAOYSA-N 0.000 abstract 5
- 235000001258 Cinchona calisaya Nutrition 0.000 abstract 5
- LOUPRKONTZGTKE-UHFFFAOYSA-N cinchonine Natural products C1C(C(C2)C=C)CCN2C1C(O)C1=CC=NC2=CC=C(OC)C=C21 LOUPRKONTZGTKE-UHFFFAOYSA-N 0.000 abstract 5
- 229960000948 quinine Drugs 0.000 abstract 5
- 230000007910 cell fusion Effects 0.000 abstract 1
- 238000013537 high throughput screening Methods 0.000 abstract 1
- MMXZSJMASHPLLR-UHFFFAOYSA-N pyrroloquinoline quinone Chemical compound C12=C(C(O)=O)C=C(C(O)=O)N=C2C(=O)C(=O)C2=C1NC(C(=O)O)=C2 MMXZSJMASHPLLR-UHFFFAOYSA-N 0.000 description 206
- 239000002609 medium Substances 0.000 description 67
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 18
- 239000000306 component Substances 0.000 description 17
- 230000015572 biosynthetic process Effects 0.000 description 14
- 230000008859 change Effects 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 241000282414 Homo sapiens Species 0.000 description 13
- 238000003786 synthesis reaction Methods 0.000 description 13
- 230000006698 induction Effects 0.000 description 12
- 102000004169 proteins and genes Human genes 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 235000014655 lactic acid Nutrition 0.000 description 9
- 239000004310 lactic acid Substances 0.000 description 9
- 230000002503 metabolic effect Effects 0.000 description 9
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 230000012010 growth Effects 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 7
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 7
- 230000014509 gene expression Effects 0.000 description 7
- 235000013922 glutamic acid Nutrition 0.000 description 7
- 239000004220 glutamic acid Substances 0.000 description 7
- 239000002054 inoculum Substances 0.000 description 7
- 238000004321 preservation Methods 0.000 description 7
- 230000002265 prevention Effects 0.000 description 7
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 7
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 7
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 238000013459 approach Methods 0.000 description 6
- 230000033228 biological regulation Effects 0.000 description 6
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 6
- 230000001954 sterilising effect Effects 0.000 description 6
- 244000068988 Glycine max Species 0.000 description 5
- 235000010469 Glycine max Nutrition 0.000 description 5
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 5
- 238000009395 breeding Methods 0.000 description 5
- 230000001488 breeding effect Effects 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 230000002537 thrombolytic effect Effects 0.000 description 5
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- 240000009088 Fragaria x ananassa Species 0.000 description 4
- 238000009629 microbiological culture Methods 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 230000000869 mutational effect Effects 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000002708 random mutagenesis Methods 0.000 description 4
- 210000004881 tumor cell Anatomy 0.000 description 4
- 108010024636 Glutathione Proteins 0.000 description 3
- 102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 3
- 108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000013368 commensalism Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 229960003180 glutathione Drugs 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 230000037353 metabolic pathway Effects 0.000 description 3
- 235000010298 natamycin Nutrition 0.000 description 3
- 239000004311 natamycin Substances 0.000 description 3
- NCXMLFZGDNKEPB-FFPOYIOWSA-N natamycin Chemical compound O[C@H]1[C@@H](N)[C@H](O)[C@@H](C)O[C@H]1O[C@H]1/C=C/C=C/C=C/C=C/C[C@@H](C)OC(=O)/C=C/[C@H]2O[C@@H]2C[C@H](O)C[C@](O)(C[C@H](O)[C@H]2C(O)=O)O[C@H]2C1 NCXMLFZGDNKEPB-FFPOYIOWSA-N 0.000 description 3
- 229960003255 natamycin Drugs 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- 229960005356 urokinase Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 2
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 244000307700 Fragaria vesca Species 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 208000012902 Nervous system disease Diseases 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 241000493924 Streptomyces gilvosporeus Species 0.000 description 2
- 229930003448 Vitamin K Natural products 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 231100000753 hepatic injury Toxicity 0.000 description 2
- 238000012188 high-throughput screening assay Methods 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 239000012533 medium component Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000007269 microbial metabolism Effects 0.000 description 2
- TZBAVQKIEKDGFH-UHFFFAOYSA-N n-[2-(diethylamino)ethyl]-1-benzothiophene-2-carboxamide;hydrochloride Chemical compound [Cl-].C1=CC=C2SC(C(=O)NCC[NH+](CC)CC)=CC2=C1 TZBAVQKIEKDGFH-UHFFFAOYSA-N 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001938 protoplast Anatomy 0.000 description 2
- 235000019710 soybean protein Nutrition 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 235000002374 tyrosine Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019168 vitamin K Nutrition 0.000 description 2
- 239000011712 vitamin K Substances 0.000 description 2
- 150000003721 vitamin K derivatives Chemical class 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 229940046010 vitamin k Drugs 0.000 description 2
- 235000020138 yakult Nutrition 0.000 description 2
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 244000189799 Asimina triloba Species 0.000 description 1
- 235000006264 Asimina triloba Nutrition 0.000 description 1
- 241000223678 Aureobasidium pullulans Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 235000009467 Carica papaya Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 108010059892 Cellulase Proteins 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 241000192091 Deinococcus radiodurans Species 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000589232 Gluconobacter oxydans Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 1
- 206010022653 Intestinal haemorrhages Diseases 0.000 description 1
- 241000588747 Klebsiella pneumoniae Species 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241001608865 Methylovorus Species 0.000 description 1
- DAYLJWODMCOQEW-TURQNECASA-N NMN zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)([O-])=O)O2)O)=C1 DAYLJWODMCOQEW-TURQNECASA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 241000186334 Propionibacterium freudenreichii subsp. shermanii Species 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 229920000377 Sinistrin Polymers 0.000 description 1
- 241000204115 Sporolactobacillus inulinus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 108010023079 activin B Proteins 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 235000013527 bean curd Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- UVMPXOYNLLXNTR-UHFFFAOYSA-N butan-1-ol;ethanol;propan-2-one Chemical compound CCO.CC(C)=O.CCCCO UVMPXOYNLLXNTR-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 229940106157 cellulase Drugs 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000001086 cytosolic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000005059 dormancy Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000002889 endothelial cell Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 108010046015 ferritin receptor Proteins 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000021474 generally recognized As safe (food) Nutrition 0.000 description 1
- 235000021473 generally recognized as safe (food ingredients) Nutrition 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 201000010235 heart cancer Diseases 0.000 description 1
- 208000024348 heart neoplasm Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 201000002313 intestinal cancer Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- -1 lactein Substances 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000008811 mitochondrial respiratory chain Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000001662 opsonic effect Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 238000006722 reduction reaction Methods 0.000 description 1
- 230000008844 regulatory mechanism Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000035806 respiratory chain Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 229960000103 thrombolytic agent Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 235000021404 traditional food Nutrition 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000005760 tumorsuppression Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/125—Casei
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses a method for preparing fermented strawberry juice with a therapeutic efficacy. The method comprises following steps: respectively carrying out nitrosoguanidine mutagenesis on bacillus natto 10261 and 10263 for producing nattokinase and pyrroloquinoline quinine, and then mixing mutation progenies of the bacillus natto 10261 and 10263; carrying out cell fusion subculture, and carrying out high throughput screening by adopting a substrate-induced adaptive strategy on the basis of a genome rearrangement technology to obtain the bacillus natto for highly producing the nattokinase and the pyrroloquinoline quinine; carrying out nitrosoguanidine mutagenesis on lactobacillus casei, and screening out lactobacillus casei caused by methionine nutritional defects; carrying out co-fermentation on the strawberry juice by adopting the screened bacillus natto and lactobacillus casei, so as to prepare the strawberry juice containing nattokinase and pyrroloquinoline quinine. According to the strawberry juice rich in nattokinase and pyrroloquinoline quinine prepared by the method, the pyrroloquinoline quinine content reaches 86-135ng/mL; and the bacillus natto activity is 410-912U/mL.
Description
Technical field
The present invention relates to microbial project and fermentation arts, be specifically related to a kind of preparation method with the fermentation strawberry juice of dietotherapy effect.
Background technology
Natto is formed through bafillus natto (Bacillus natto) fermentation by soybean, has multiple physiological effect:
1. natto is to the effect of cardiovascular system: a kind of significant physiological activator Nattokinase (Nattokinase in natto, NK) be can thrombolytic protein, be made up of 275 amino acid residues, molecular weight about 27KD, nontoxic, have no side effect, be a kind of serine protease, its thrombolytic effect even exceedes Thrombolytic agent urokinase.Nattokinase, except having direct thrombolytic effect, also has and promotes that venous endothelial cell produces the ability of PLA, thus indirectly show its thrombolysis activity.Natto Linoleic acid accounts for 50% of full-cream matter, and linoleic acid can reduce cholesterol level in blood plasma, has prevention of arterial sclerosis, heart disease and hypertensive effect, has thrombolytic effect;
2. natto is to the effect of digestive system: soybean protein changes into soluble polypeptide and amino acid through the effect of Nadou enzyme, is conducive to absorption of human body.Containing more than 1,000,000,000 Bacillus nattos in 1g natto, Bacillus natto breeding is fast, can consume the oxygen in enteron aisle, can suppress to cause the spoilage organisms such as the shigella dysenteriae of abnormal fermentation in intestines, promote lactic acid bacteria breeding, regulate intestinal bacterium balance, prevention dysentery, enteritis and constipation etc.Soybean have accumulated the enzyme groups such as a large amount of protease, amylase, lipase, esterase, cellulase and urase through fermenting bacillus natto, and these biology enzymes can effectively be nursed one's health promotion and digest and assimilate in digestive system.Bafillus natto is utilizing soybean protein to carry out in the process of breeding by decomposing, and can produce the stickums such as a large amount of ferment, vitamin, polyglutamic acid and polyfructosan, it is overlayed on gastrointestinal mucosal surfaces and plays a protective role, and can alleviate drunk when drinking.Bacillus natto can also kill intestinal bleeding Escherichia coli;
3. natto is to immune effect: found by the zoopery inoculating Bacillus natto, natto can improve Abwehrkraft des Koepers, gets rid of the staphylococcus invaded, and can also bring out body interferon and generate, strengthen immunity of organisms; Active material is contained as saponin, Cobastab in natto
2, vitamin E etc., every day is edible can remove carcinogen in body, and pre-anti-cancer occurs, and can softening blood vessel, promotes that skin is smooth;
4. skeleton development is promoted: vitamin K
2calcium and protein bound can be promoted thus promote that bone is formed, playing an important role in skeleton-forming process, and vitamin K in natto
2content is hundreds of times of other fermented foods, has effect of the disease of old people such as prevention of osteoporosis, pain in the back.
In recent years find that natto also has other abundanter physiological function widely, come from its another kind of significant physiological activator---PQQ (pyrroloquinoline quinone, PQQ), it is the third prothetic group found in bacterial dehydrogenase after flavin nucleotide and nicotinamide nucleotide, and chemical name is 4,5-dihydro-4,5-titanium dioxide-1-hydrogen pyrroles (2,3f) quinone-2,7,9-tricarboxylic acids, has another name called Methaxatin.Although only minority bacterium such as Methylovorus, Deinococcus radiodurans, Gluconobacter oxydans, Klebsiella pneumoniae etc. can synthesize PQQ under natural conditions, all find containing trace P QQ in each Plants, animal and human body.Japanese Scientists determines the PQQ content in 26 kinds of common food, to find in 1 gram of food PQQ content at 3.65-61 nanogram not etc., such as, parsley in vegetables, green pepper, Chinese grooseberry in fruit, pawpaw, the green tea in drink, oolong tea, and the bean curd that people often eat.It should be noted that in the middle of japanese traditional food natto, PQQ content is the highest, reaches 61 ng/g.
PQQ is as a kind of oxidoreducing enzyme prothetic group be prevalent in animal and plant tissue, although content is very low, but act on important, be not only a kind of newfound mitochondrial respiratory chain component, participate in catalysis biological vivo oxidation reduction reaction, also there is very various biologically active, the many dysbolisms of mammal during shortage, can be caused, be considered to a kind of novel vitamin.PQQ has mammiferous major physiological effect:
1. improve immune function of human body: PQQ, as the necessary factor of human developmental, can stimulate human body cell to grow, especially human activin B cell, T cell comprehensively, improve immune function of human body;
2. prevent and treat hepatic injury: PQQ can significantly reduce serum bilirubin and gpt level, conditioning hepatic injury, has fabulous curative effect to liver diseases;
3. the injury of radical pair human body is reduced: PQQ is a kind of oxidoreducing enzyme prothetic group, participate in organism internal oxidition reduction reaction, effectively can remove interior free yl, reduce the various diseases that radical pair human injury causes, as heart disease, cancer and all kinds of inflammation;
4. various the nervous system disease is nursed one's health: PQQ can promote that neural factor synthesizes, and nurses one's health various the nervous system disease in vivo;
5. promote Amino Acid Absorption: PQQ is the prothetic group of quinoprotein enzyme, participate in respiratory chain electron transmission, can Amino Acid Absorption be promoted in human body;
6. growth promoting effects factor synthesis: growth factor is the hormone of human growth, and PQQ can stimulate human body cell to grow, increase cell density, trace P QQ just can improve metabolic capability and the GF of bio-tissue;
7. senile dementia prevention and cure: PQQ has and repairs nerve fibre, activation neuron, activates the ability of dormancy nerve cell, can effectively senile dementia prevention and cure and Improving memory power;
8. promote glutathione synthesis: glutathione has important antioxidation and integrates detoxication, and PQQ can promote body glutathione synthesis, prevent cataract from occurring and the accumulation of liver bilirubin;
9. it is ANK cell that extremely strong anti-cancer function: PQQ activates NK (NK) cell, makes it have and kills function of tumor; The immunocytes such as NK cell are assembled, more effectively killing off tumor cells; Closed tumour cell carries Human Placental Ferritin Receptor, blocks its function, Tumor suppression growth, transfer; Destroy tumour cell double-layer of lipoid, make oncolysis dead; DNA of tumor cell is stoped to copy, its apoptosis short.
In wholefood, the exclusive NK of natto, and PQQ content is the abundantest.NK and PQQ in natto is produced by bafillus natto.Natto is routine health food, bafillus natto is generally regarded as safe food-grade microorganisms (GRAS microorganism), directive breeding is carried out to bafillus natto, then ferment altogether with lactic acid bacteria, the food of NK and PQQ is rich in preparation, supplements NK and PQQ, to give full play to the physiology opsonic action of NK and PQQ significant for people in diet.
Strawberry, containing enriching Vc, to artery sclerosis, coronary heart diseases and angina pectoris, cerebral hemorrhage, hypertension, high fat of blood etc., has active prevention effect, can also consolidate gums, fresh breath, moist throat.Strawberry contains a large amount of pectin and cellulose, can promote gastrointestinal peristalsis, helps digest, improve constipation, prevention hemorrhoid, intestinal cancer.Strawberry juice remains the nutritional labeling of strawberry.Strawberry juice, after lactobacillus-fermented, will form many dietotherapy materials such as lactein, surfactant fatty acid, organic acid based on lactic acid further.Lactobacillus-fermented decapacitation produces outside many dietotherapy compositions, can also give pleasant sweet sour mouthfeel.Bacillus natto to ferment then can produce NK and PQQ.The present invention, by seed selection bafillus natto and Lactobacillus casei and common fermentation thereof, develops the dietotherapy fermentation strawberry juice being rich in NK and PQQ.If but Lactobacillus casei and bafillus natto grow imbalance in same system that a kind of bacterium can be caused in competition to repel another kind, fermentation cannot be carried out smoothly altogether.About physiological property, even if under wild state, lactic acid bacteria protein in cell wall enzyme PrtS also only has minority bacterial strain to have and vigor is not high, decomposing protein obtains the scarce capacity of essential amino acid, and bafillus natto has stronger prolease activity, its decomposing protein produces amino acid and peptide can meet lactic acid bacteria to amino acid whose demand.Bafillus natto amphimicrobian, also promotes lactobacter growth by consuming oxygen and produces acid.In the present invention, except there is not strict commensalism relation between the two in bafillus natto and Lactobacillus casei, more make Lactobacillus casei form strict commensalism relation because forming methionine auxotrophicity (Met-) with bafillus natto by seed selection means, thus ensure that the common fermentation of Lactobacillus casei and bafillus natto is carried out smoothly.
The metabolic pathway of bafillus natto synthesis NK and PQQ is not yet completely clear so far, thus cannot be improved the productive rate of bafillus natto synthesis NK and PQQ by rationality optimization means.And due to sugar, amino acid, lipid, communicating and close association between the large organic metabolism of nucleotides four, microbial cell metabolism network is made not only to demonstrate rigidity (Rigidity) but also demonstrate flexibility (Plasticity), be in strictly Guaranteed, rigidity shows as pulls one hair and move the whole body, thus in most cases, even if understand metabolic pathway, the sudden change of fixed point rationality also can not obtain desired phenotypes, and flexibility shows as being in different node in whole metabolism network but after relevant approach carries out collaborative sudden change, the metabolism attribute made new advances can be showed.For improving the productive rate of bafillus natto synthesis NK and PQQ, do not understand that its metabolic pathway does not become impassable obstacle, as long as there is suitable irrational optimization means (Unrationaloptimization technique), to likely synthesize relevant main flow with NK and PQQ and collateral branch's approach is planned as a whole to optimize, realize the collaborative sudden change of multidigit point, and make multidigit point work in coordination with the phenotype of sudden change from mutation library saliency by high flux screening, the target improving bafillus natto synthesis NK and PQQ productive rate can be realized.
Random mutation is modal irrational optimization means, although it can produce the enough large mutation library of mutational site quantity, but in mutation library, each mutational site disperses independent of in individual cells often, each other cannot optimum organization, and scarcely produce visible phenotypic, thus most sudden change is disappeared can not be screened in mutation library.
Genome rearrangement (Genome Shuffling) is the novel mutation breeding technologies grown up on the basis of random mutation.It is being produced on the basis of the enough large mutation library of mutational site quantity by random mutation, is making the optimum organization of each mutational site further by Fusion of Cells, thus make the rising of mutation index level particularly increase a large amount of phenotype visible mutation.Genome rearrangement is that the strain improvement utilizing this flexibility of microbial metabolism network to carry out multi-point cooperative sudden change provides technical support.Zhang etc. (2002) first obtain a mutation library with classic mutagenesis method, filter out several forward mutants as strain of setting out, then by the mode of many wheel recursion protoplast fusions, numerous gene is recombinated at random, realize genome rearrangement, from mutation library, finally filter out proterties by the object bacterial strain promoted; Stephanopoulos (2002) has transformed Bacterial phenotype by genome rearrangement; Patnaik etc. (2002) utilize genome product technology to achieve the improvement of a strain industrial strain of Bacillus acidi lactici, make it be 3 times of wild strain of setting out at pH 4.0 times lactic acid productions; Gao etc. (2012), by two-wheeled genome rearrangement, make Clostridium acetobutylicumCICC 8012 produce Acetone-Butanol-Ethanol (ABE) and improve 34.53%; Ge etc. (2012) obtain Saccharomyces cerevisiae GS3-10 by genome rearrangement, it reaches 69.48% and 100% to the conversion ratio of pentose and hexose, and starting strain is 14.83% and 100%, alcohol yied reaches 47.08g/L, and starting strain is 18.12g/L; Kang etc. (2011), by genome rearrangement, make Aureobasidium pullulans produce the blue polysaccharide in general Shandong and increase substantially, and inheritance stability; Zheng etc. (2010) improve D-ALPHA-Hydroxypropionic acid productive rate and the acid resistance of Sporolactobacillus inulinus ATCC 15538 by genome rearrangement; John etc. (2008) by the genome rearrangement of protoplast fusion formula, the Lactic Acid High-yield Strains that to obtain with cassava-bagasse be matrix; Yu etc. (2008) obtain the resistance to degree of sugar by genome rearrangement and improve thus the Lactobacillus rhamnosus of lactic acid yield increase; Wang etc. (2007) obtain acid resistance by genome rearrangement and improve thus the Lactobacillus rhamnosus of lactic acid yield increase.
Genome rearrangement also provides support for carrying out microbial metabolism group Epidemiological Analysis.Through genome rearrangement, its genetic background of object bacterium of metabolism optimization derives from the bacterium that sets out, therefore by the protein expression profiles difference of comparison object bacterium with the bacterium that sets out, be aided with metabolic fluxes and metabolic control analysis technology, the key enzyme that causes metabolism to be optimized and the regulatory mechanism about approach can be resolved.Luo etc. (2012) make natamycin (natamycin) productive rate of Streptomyces gilvosporeus ATCC 13326 obviously raise by genome rearrangement, the protein expression profiles of Streptomyces gilvosporeus ATCC 13326 occurs obviously to change, 34 kinds of protein expressions rise and 20 kinds of protein expressions declines, and prompting is synthesized the relevant metabolism network widely that involves with natamycin and is optimized; Zhang etc. (2010), by genome rearrangement, make Propionibacteriumshermanii produce V
b12increase substantially, after resetting, bacterial strain 38 kinds of protein expressions change, and wherein 22 kinds of protein expressions rise and 16 kinds of protein expressions declines, expressing in the 22 kinds of albumen risen, have 6 kinds to be V
b12enzyme in route of synthesis, prompting and V
b12synthesize the relevant metabolism network widely that involves to be optimized.
But at present there is certain defect, mainly onrelevant between seed selection culture medium and fermentation medium in genome rearrangement on strategy, the bacterial strain that seed selection is arrived when fermenting target product productive rate far below expection.For this problem, the present invention is when carrying out genome rearrangement seed selection, a certain proportion of fermentation medium component is added in seed selection flat board, and in fermentation medium, add the dull and stereotyped component of a certain proportion of seed selection, make to be formed between seed selection with fermentation two links to associate, ensured that the bacterial strain that seed selection link shows high yield phenotype still shows high yield phenotype when fermenting, this is substrate for induction adaptive strategy of the present invention.Therefore, when PQQ phenotype of holding concurrently to bafillus natto high yield NK carries out genome rearrangement seed selection, in seed selection flat board, add certain proportion strawberry juice, then add certain proportion bean sprout juice when strawberry juice ferments.
Summary of the invention
The invention provides a kind of preparation method with the fermentation strawberry juice of dietotherapy effect.The present invention adopts substrate for induction adaptive strategy further in genome rearrangement technical foundation, to bafillus natto likely synthesize relevant main flow with NK and PQQ and collateral branch's approach is planned as a whole to optimize, realize the collaborative sudden change of multidigit point, and then make multidigit point work in coordination with the phenotype of sudden change from mutation library saliency by high flux screening, obtain and can to hold concurrently the bafillus natto BN-NKPQQ-RWX-507 of PQQ by high yield NK in strawberry juice fermentation.Meanwhile, methionine auxotrophicity (Met is obtained by random mutagenesis
-) Lactobacillus casei (Lactobacillus casei Shirota-Met
-, LcS-Met
-).LcS-Met
-higher than BN-NKPQQ-RWX-507 in the speed of growth, but the former relies on the latter's nutrition, is formed between the two and stablizes symbiosis, ensured that common fermentation completes smoothly, thus obtain the strawberry juice being rich in NK and PQQ.
There is a preparation method for the fermentation strawberry juice of dietotherapy effect, comprise the following steps:
1), nitrosoguanidine mutagenesis is carried out respectively by producing the hold concurrently bafillus natto 10261 of PQQ and bafillus natto 10263 of NK; Then mutagenic progeny both mixing, carry out Fusion of Cells Secondary Culture, genome rearrangement technical foundation further adopts substrate for induction adaptive strategy, and high flux screening obtains high yield NK and to hold concurrently the bafillus natto of PQQ, called after bafillus natto BN-NKPQQ-RWX-507;
Fusion of Cells Secondary Culture realizes genome segment S9, and the predominant mutation of all mutagenic progeny of bafillus natto 10261 and 10623 is optimized integration.If necessary, second can be carried out take turns or take turns more mutagenesis and fusion fusion offspring, until it is high and grow vigorous, inheritance stability, be suitable as the high yield NK producing bacterial strain and hold concurrently PQQ bafillus natto to select NK PQQ productive rate of holding concurrently.
2), by Lactobacillus casei (Lactobacillus casei Shirota) carry out nitrosoguanidine mutagenesis, therefrom filter out the Lactobacillus casei of methionine auxotroph, called after Lactobacillus casei LcS-Met
-(Lactobacillus casei Shirota-Met
-);
3) by bafillus natto BN-NKPQQ-RWX-507 and Lactobacillus casei LcS-Met
-ferment strawberry juice altogether, obtains the strawberry juice being rich in NK and PQQ, and the strawberry juice being rich in NK and PQQ obtained is the fermentation strawberry juice with dietotherapy effect.
The present invention adopts substrate for induction adaptive strategy further in genome rearrangement technical foundation, to bafillus natto likely synthesize relevant main flow with NK and PQQ and collateral branch's approach is planned as a whole to optimize, realize the collaborative sudden change of multidigit point, and then make multidigit point work in coordination with the phenotype of sudden change from mutation library saliency by high flux screening, obtain and can to hold concurrently the bafillus natto BN-NKPQQ-RWX-507 of PQQ by high yield NK in strawberry juice fermentation.Meanwhile, methionine auxotrophicity (Met is obtained by random mutagenesis
-) Lactobacillus casei LcS-Met
-.
Lactobacillus casei and bafillus natto are fermented smoothly altogether, should symbiosis be formed between the two.Strategy of the present invention makes to compete the Lactobacillus casei be dominant under normal circumstances to become methionine auxotrophicity (LcS-Met
-), thus in metabolism, dependence being formed to bafillus natto BN-NKPQQ-RWX-507, the methionine (Met) required for it is supplied by bafillus natto, namely forms strict commensalism relation.Although LcS-Met
-higher than BN-NKPQQ-RWX-507 in the speed of growth, but the former relies on the latter's nutrition, is formed and stablizes symbiosis, ensured that common fermentation completes smoothly, thus obtain the strawberry juice being rich in NK and PQQ between two bacterium.
Bafillus natto used and Lactobacillus casei all belong to grade-safe microorganism, and what fermentation obtained altogether is rich in the strawberry juice of NK and PQQ, and PQQ content reaches 86-135ng/mL.NK vigor reaches 410-912U/mL.The strawberry juice obtained is rich in Nattokinase and PQQ, has the intrinsic flavour of strawberry juice and the rear distinctive local flavor of fermentation.
Step 1) in, bafillus natto 10261 and bafillus natto 10263 adopt prior art, bafillus natto 10261 from Chinese industrial Microbiological Culture Collection administrative center (CICC), address: No. 24, Road, Jiuxianqiao, Chaoyang District, Beijing City institute No. 6 building; Preservation date is 2002, and bacterial classification keeps being numbered 10261; Bafillus natto 10263 from Chinese industrial Microbiological Culture Collection administrative center (CICC), address: No. 24, Road, Jiuxianqiao, Chaoyang District, Beijing City institute No. 6 building; Preservation date is 2002, and bacterial classification keeps being numbered 10263; Lactobacillus casei (Lactobacillus casei Shirota) is from chlorella yakult (Shanghai) Co., Ltd.; Little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb adopts commercially available prod, and purchased from Yuan Ke bio tech ltd, Jiaxing, article number is YK-Ab-013.
High flux screening after described substrate for induction adaptibility gene group rearrangement specifically comprises: (strawberry juice accounts for the 10%-15% of dull and stereotyped total amount 1. to prepare 2 dull and stereotyped bean sprout juice strawberry juice solid mediums, seed selection culture medium is associated with between fermentation medium, this is substrate for induction adaptive strategy of the present invention), little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb allocates into by one of them, form dull and stereotyped A, agarose-fibrin is allocated into by another, forms dull and stereotyped B; 2. the mutagenesis of bafillus natto 10261 and bafillus natto 10263 merged after offspring is coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, make dull and stereotyped A and dull and stereotyped B photocopy each other dull and stereotyped; 3. in dull and stereotyped A, high yield PQQ mutagenesis is merged offspring's periphery of bacterial colonies and is formed some visual precipitation line, judges that producing PQQ measures size according to the large I naked eyes of precipitation loop diameter; 4. in dull and stereotyped B, high yield NK mutagenesis is merged offspring's periphery of bacterial colonies and is formed transparent circle, can judge to produce NK vigor height by naked eyes according to transparent circle diameter; 5., in dull and stereotyped A and dull and stereotyped B, high yield PQQ bacterium colony and high yield NK bacterium colony are in same position person, is high yield NK and holds concurrently the bafillus natto of PQQ.
The hold concurrently bafillus natto BN-NKPQQ-RWX-507 of PQQ of the high yield NK obtained is preserved in inclined-plane bean sprout juice strawberry juice solid medium.
Described dull and stereotyped bean sprout juice strawberry juice solid medium and inclined-plane bean sprout juice strawberry juice solid medium, in 1L, are made up of the component of following amount:
Further preferably, described dull and stereotyped bean sprout juice strawberry juice solid medium and inclined-plane bean sprout juice strawberry juice solid medium, in 1L, are made up of the component of following amount:
The preparation of described bean sprout juice: the soybean 500g just sprouted, add water 2500mL, boils after being concentrated into 1000mL and filter, obtain bean sprout juice.
The formula of this dull and stereotyped bean sprout juice strawberry juice solid medium is conducive to bafillus natto bacterium colony and is formed and high flux screening.The formula of this inclined-plane bean sprout juice strawberry juice solid medium is conducive to bafillus natto preservation.
In the present invention, when adopting genome rearrangement technology seed selection bafillus natto BN-NKPQQ-RWX-507, a certain proportion of fermentation medium component (strawberry juice) is added in seed selection flat board, and in fermentation medium, add the dull and stereotyped component (bean sprout juice) of a certain proportion of seed selection, make to be formed between seed selection with fermentation two links to associate, the bacterial strain impelling seed selection link to show high yield phenotype still shows high yield phenotype when fermenting, and this is substrate for induction adaptive strategy of the present invention.
Step 2) in, the described Lactobacillus casei therefrom filtering out methionine auxotroph, specifically comprise: 1. prepare 2 dull and stereotyped MRS solid mediums, methionine (Met) is allocated into (Met addition is 10-15mg/L) by one of them, for dull and stereotyped C, another is simple MRS solid medium flat board (dull and stereotyped D), is dull and stereotyped D; 2. after the Lactobacillus casei (Lactobacillus caseiShirota) after mutagenesis being coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, makes dull and stereotyped C and dull and stereotyped D photocopy each other flat board; 3. at the same position of dull and stereotyped C and dull and stereotyped D, there is bacterium colony in dull and stereotyped C and bacterium colony does not appear in dull and stereotyped D, or the bacterium colony on dull and stereotyped C is significantly greater than the bacterium colony on dull and stereotyped D, then this bacterium colony is methionine auxotroph Lactobacillus casei, called after Lactobacillus casei LcS-Met
-, be preserved in inclined-plane MRS solid medium.
Described dull and stereotyped MRS solid medium and inclined-plane MRS solid medium, in 1L, are made up of the component of following amount:
The pH value of this MRS solid medium remains on 6.2 ~ 6.4.
This MRS solid medium is conducive to the screening of the formation of Lactobacillus casei bacterium colony and methionine auxotroph Lactobacillus casei.
In the present invention, random mutagenesis techniques is adopted to obtain methionine auxotrophicity (Met
-) Lactobacillus casei (Lactobacillus casei Shirota-Met
-, LcS-Met
-).LcS-Met
-higher than BN-NKPQQ-RWX-507 in the speed of growth, but the former relies on the latter's nutrition, formed between the two and stablize symbiosis, realized the common fermentation of bafillus natto and Lactobacillus casei by the strategy building symbiosis, obtain the strawberry juice being rich in NK and PQQ.
Step 3) in, before common fermentation, by BN-NKPQQ-RWX-507 and LcS-Met
-carry out activation culture respectively, BN-NKPQQ-RWX-507 carries out activation culture in bean sprout juice strawberry juice fluid nutrient medium, and cultivation temperature is 34 ~ 36 DEG C (preferably 35 DEG C), LcS-Met
-in MRS fluid nutrient medium, carry out activation culture, cultivation temperature is 36 ~ 38 DEG C (preferably 37 DEG C).
Described bean sprout juice strawberry juice fluid nutrient medium, in 1L, is made up of the component of following amount:
Strawberry juice 100 ~ 150mL;
Sucrose 4.0 ~ 6.0g;
Bean sprout juice surplus.
Described bean sprout juice strawberry juice fluid nutrient medium, in 1L, preferably, is made up of the component of following amount:
Strawberry juice 100 ~ 150mL;
Sucrose 5.0g;
Bean sprout juice surplus.
The formula of this bean sprout juice strawberry juice fluid nutrient medium is conducive to bafillus natto Multiplying culture.Prepared by bean sprout juice: the soybean 500g just sprouted, add water 2500mL, boils after being concentrated into 1000mL and filter, obtain bean sprout juice.
Described MRS fluid nutrient medium, in 1L, is made up of the component of following amount:
The pH value of this MRS fluid nutrient medium remains on 6.2 ~ 6.4.
This MRS fluid nutrient medium is conducive to Lactobacillus casei Multiplying culture.
By BN-NKPQQ-RWX-507 and LcS-Met
-fermentation is containing the fermentation medium of strawberry juice altogether, specifically comprises: by BN-NKPQQ-RWX-507 and LcS-Met after activation
-mixing, forms mixed bacteria liquid, mixed bacteria liquid is seeded to the fermentation medium containing strawberry juice, and gauze sealing obtains the strawberry juice being rich in NK and PQQ after cultivating.
The described fermentation medium containing strawberry juice, in 1L, is made up of the component of following amount:
The preparation of described strawberry juice comprises: add strawberry in water, is milled into juice.As added 10 ~ 25g strawberry in 100mL water, be milled into juice.
In mixed bacteria liquid, described BN-NKPQQ-RWX-507 and LcS-Met
-hybrid density than for 1:2 ~ 1:5.
The inoculum concentration that described mixed bacteria liquid is seeded to containing the fermentation medium of strawberry juice is 1% ~ 5%.
The condition that described gauze sealing is cultivated is: 24h ~ 36h is cultivated in 37 DEG C ~ 42 DEG C six layers of gauze sealings.
When fermenting altogether, in the fermentation medium containing strawberry juice, interpolation tyrosine and glutamic acid carry out metabolic regulation to BN-NKPQQ-RWX-507, promote PQQ synthesis, add maltose and metabolic regulation is carried out to BN-NKPQQ-RWX-507, promote that NK generates, add bean sprout juice and promote the propagation of BN-NKPQQ-RWX-507 in strawberry juice sweat.In the present invention, bafillus natto and Lactobacillus casei seed selection and the fermentation strawberry juice that fermentation is standby altogether thereof are rich in Nattokinase and PQQ, have distinctive local flavor after the intrinsic flavour of strawberry juice and fermentation.
Compared with prior art, tool of the present invention has the following advantages:
One, the present invention use bafillus natto and Lactobacillus casei all belong to grade-safe microorganism.
Two, genome rearrangement technical optimization NK and PQQ route of synthesis is adopted first, to bafillus natto likely synthesize relevant main flow with NK and PQQ and collateral branch's approach is planned as a whole to optimize, realize the collaborative sudden change of multidigit point, and then make multidigit point work in coordination with the phenotype of sudden change from mutation library saliency by high flux screening.Simultaneously, genome rearrangement technical foundation adopts substrate for induction adaptive strategy further, ensureing that the bacterial strain that seed selection link shows high yield phenotype still shows high yield phenotype when fermenting, having obtained and can to hold concurrently the bafillus natto BN-NKPQQ-RWX-507 of PQQ by high yield NK in strawberry juice fermentation.
Three, the strategy building symbiosis is adopted to realize the common fermentation of bafillus natto and Lactobacillus casei first.Methionine auxotrophicity (Met is obtained by random mutagenesis
-) Lactobacillus casei LcS-Met
-.LcS-Met
-higher than BN-NKPQQ-RWX-507 in the speed of growth, but the former relies on the latter's nutrition, is formed between the two and stablizes symbiosis, ensured that common fermentation completes smoothly, thus obtain the strawberry juice being rich in NK and PQQ.
Four, from structure, PQQ forms by forming peptide bond connection cyclisation between tyrosine and glutamic acid.The present invention, by adding tyrosine and glutamic acid carries out metabolic regulation to BN-NKPQQ-RWX-507 in containing the fermentation medium of strawberry juice, promotes PQQ synthesis.By adding maltose in the fermentation medium containing strawberry juice, metabolic regulation being carried out to BN-NKPQQ-RWX-507, promoting that NK generates.By adding the propagation of bean sprout juice promotion BN-NKPQQ-RWX-507 in strawberry juice sweat in containing the fermentation medium of strawberry juice, thus obtain the strawberry juice being rich in NK and PQQ, PQQ content reaches 86-135ng/mL.NK vigor reaches 410-912U/mL.The strawberry juice obtained is rich in Nattokinase and PQQ, has the intrinsic flavour of strawberry juice and smell.
Detailed description of the invention
In an embodiment, relevant culture medium is formulated as follows,
A the bean sprout juice strawberry juice fluid nutrient medium described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
Strawberry juice 130mL;
Sucrose 5.0g;
Bean sprout juice surplus;
The formula of this bean sprout juice strawberry juice fluid nutrient medium is conducive to bafillus natto Multiplying culture.Prepared by bean sprout juice: the soybean 500g just sprouted, add water 2500mL, boils after being concentrated into 1000mL and filter, obtain bean sprout juice.
B the bean sprout juice strawberry juice solid medium (flat board) described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
The formula of this bean sprout juice strawberry juice solid medium (flat board) is conducive to bafillus natto bacterium colony and is formed and high flux screening.
C the bean sprout juice strawberry juice solid medium (inclined-plane) described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
The formula of this bean sprout juice strawberry juice solid medium (inclined-plane) is conducive to the preservation of bafillus natto.
D the MRS fluid nutrient medium described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
This MRS fluid nutrient medium is conducive to Lactobacillus casei Multiplying culture.
E the MRS solid medium (flat board) described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
This MRS solid medium is conducive to Lactobacillus casei bacterium colony and is formed and screening.
F the MRS solid medium (inclined-plane) described in () has been prepared after, 121 DEG C of sterilizing 15min, in 1L, are made up of the component of following amount:
This MRS solid medium (inclined-plane) is conducive to Lactobacillus casei preservation.
G the strawberry juice fermentation medium described in (), in 1L, is made up of the component of following amount:
H the preparation of the strawberry juice described in () comprises: add 200g strawberry in 1000mL water, be milled into juice.
In the embodiment of the present invention, bafillus natto 10261 and bafillus natto 10263 adopt prior art, bafillus natto 10261 from Chinese industrial Microbiological Culture Collection administrative center (CICC), address: No. 24, Road, Jiuxianqiao, Chaoyang District, Beijing City institute No. 6 building; Preservation date is 2002, and bacterial classification keeps being numbered 10261; Bafillus natto 10263 from Chinese industrial Microbiological Culture Collection administrative center (CICC), address: No. 24, Road, Jiuxianqiao, Chaoyang District, Beijing City institute No. 6 building; Preservation date is 2002, and bacterial classification keeps being numbered 10263; Lactobacillus casei (Lactobacillus casei Shirota) is from chlorella yakult (Shanghai) Co., Ltd.; Little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb adopts commercially available prod, and purchased from Yuan Ke bio tech ltd, Jiaxing, article number is YK-Ab-013.
Embodiment 1
The present invention is by bafillus natto and Lactobacillus casei seed selection and be total to the standby strawberry juice being rich in NK and PQQ of fermentation, comprises the following steps:
(1) high yield NK holds concurrently the seed selection of bafillus natto BN-NKPQQ-RWX-507 of PQQ
Adopt substrate for induction adaptive strategy, obtain high yield NK by genome rearrangement and High Throughput Screening Assay to hold concurrently the bafillus natto BN-NKPQQ-RWX-507 of PQQ, concrete grammar is: first build bafillus natto mutation library, and the bafillus natto 10261 and 10263 of the PQQ that held concurrently by acquired product NK carries out nitrosoguanidine mutagenesis respectively; Then mutagenic progeny both mixing, carry out Fusion of Cells (fusogen is Macrogol 4000), Secondary Culture, realize genome segment S9, the predominant mutation of all mutagenic progeny of bafillus natto 10261 and 10623 is optimized integration, selects NK PQQ productive rate of holding concurrently high and grow vigorous, inheritance stability, be suitable as the high yield NK producing bacterial strain and hold concurrently the bafillus natto of PQQ.
Mutation library high flux screening: (strawberry juice accounts for the 10-15% of dull and stereotyped total amount 1. to prepare 2 bean sprout juice strawberry juice solid medium flat boards, seed selection culture medium is associated with between fermentation medium, this is substrate for induction adaptive strategy of the present invention), little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb allocates into by one of them, form dull and stereotyped A, agarose-fibrin is allocated into by another, forms dull and stereotyped B; 2. the mutagenesis of bafillus natto 10261 and bafillus natto 10263 merged after offspring is coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, make dull and stereotyped A and dull and stereotyped B photocopy each other dull and stereotyped; 3. in dull and stereotyped A, high yield PQQ mutagenesis is merged offspring's periphery of bacterial colonies and is formed some visual precipitation line, judges that producing PQQ measures size according to the large I naked eyes of precipitation loop diameter; 4. in dull and stereotyped B, high yield NK mutagenesis is merged offspring's periphery of bacterial colonies and is formed transparent circle, can judge to produce NK vigor height by naked eyes according to transparent circle diameter; 5., in dull and stereotyped A and dull and stereotyped B, high yield PQQ bacterium colony and high yield NK bacterium colony are in same position person, is high yield NK and holds concurrently the bafillus natto of PQQ.The high yield NK obtained holds concurrently the bafillus natto called after BN-NKPQQ-RWX-507 of PQQ, is preserved in bean sprout juice strawberry juice solid medium (inclined-plane).
(2) methionine auxotrophicity (Met
-) Lactobacillus casei (LcS-Met
-) seed selection
Lactobacillus casei (Lactobacillus casei Shirota) is carried out nitrosoguanidine mutagenesis, therefrom filters out methionine auxotroph (LcS-Met
-).
LcS-Met
-screening: 1. prepare 2 MRS solid mediums dull and stereotyped, methionine (Met) is allocated into (dull and stereotyped C, Met addition is 10-15mg/L) by one of them, and another is simple MRS flat board (dull and stereotyped D); 2. after the mutagenic progeny of Lactobacillus casei (Lactobacillus casei Shirota) being coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, makes dull and stereotyped C and dull and stereotyped D photocopy each other flat board; 3. at the same position of dull and stereotyped C and dull and stereotyped D, there is bacterium colony in dull and stereotyped C and bacterium colony does not appear in dull and stereotyped D, or the bacterium colony on dull and stereotyped C is significantly greater than the bacterium colony on dull and stereotyped D, then this bacterium colony methionine auxotroph Lactobacillus casei, called after LcS-Met
-, be preserved in MRS solid medium (inclined-plane).
(3) activation culture of BN-NKPQQ-RWX-507
The BN-NKPQQ-RWX-507 be stored in bean sprout juice strawberry juice solid medium (inclined-plane) is got a ring, is seeded to the activation of bean sprout juice strawberry juice fluid nutrient medium, cultivation temperature 35 DEG C, cultivate end inoculum density and reach 10
9about cfu/mL.
(4) LcS-Met
-activation culture
The LcS-Met in MRS solid medium (inclined-plane) will be stored in
-get a ring, be seeded to MRS fluid nutrient medium 37 DEG C of activation culture, cultivate end inoculum density and reach 10
9about cfu/mL.
(5) fermentation being rich in the strawberry juice of NK and PQQ is standby
By BN-NKPQQ-RWX-507 and the LcS-Met of activation
-mixing, makes the two density ratio in mixed bacteria liquid be 1:2 (1 × 10
8cFM/mL:2 × 10
8cFM/mL), mixed bacteria liquid is with the fermentation medium of 1% inoculum concentration inoculation containing strawberry juice, and 24h is cultivated in 42 DEG C of six layers of gauze sealings, obtains the strawberry juice being rich in NK and PQQ.Containing contained in the fermentation medium of strawberry juice bean sprout juice, tyrosine, glutamic acid and maltose, NK and PQQ is synthesized to BN-NKPQQ-RWX-507 and carry out metabolic regulation, bean sprout juice is conducive to bafillus natto propagation, maltose is conducive to NK synthesis, and PQQ is connected cyclisation with glutamic acid by peptide bond by tyrosine and forms.After fermentation ends, NK vigor 410U/mL in strawberry juice, PQQ content 86ng/mL.The strawberry juice obtained is rich in Nattokinase and PQQ, has the intrinsic flavour of strawberry juice and the rear distinctive local flavor of fermentation.
Embodiment 2
The present invention is by bafillus natto and Lactobacillus casei seed selection and be total to the standby strawberry juice being rich in NK and PQQ of fermentation, comprises the following steps:
(1) high yield NK holds concurrently the seed selection of bafillus natto BN-NKPQQ-RWX-507 of PQQ
Adopt substrate for induction adaptive strategy, obtain high yield NK by genome rearrangement and High Throughput Screening Assay to hold concurrently the bafillus natto BN-NKPQQ-RWX-507 of PQQ, concrete grammar is: first build bafillus natto mutation library, and the bafillus natto 10261 and 10263 of the PQQ that held concurrently by acquired product NK carries out nitrosoguanidine mutagenesis respectively; Then mutagenic progeny both mixing, carry out cytoplasmic fusion (fusogen is Macrogol 4000), Secondary Culture, realize genome segment S9, the predominant mutation of all mutagenic progeny of bafillus natto 10261 and 10623 is optimized integration, selects NK PQQ productive rate of holding concurrently high and grow vigorous, inheritance stability, be suitable as the high yield NK producing bacterial strain and hold concurrently the bafillus natto of PQQ.
Mutation library high flux screening: (strawberry juice accounts for the 10-15% of dull and stereotyped total amount 1. to prepare 2 bean sprout juice strawberry juice solid medium flat boards, seed selection culture medium is associated with between fermentation medium, this is substrate for induction adaptive strategy of the present invention), little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb allocates into by one of them, form dull and stereotyped A, agarose-fibrin is allocated into by another, forms dull and stereotyped B; 2. the mutagenesis of bafillus natto 10261 and bafillus natto 10263 merged after offspring is coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, make dull and stereotyped A and dull and stereotyped B photocopy each other dull and stereotyped; 3. in dull and stereotyped A, high yield PQQ mutagenesis is merged offspring's periphery of bacterial colonies and is formed some visual precipitation line, judges that producing PQQ measures size according to the large I naked eyes of precipitation loop diameter; 4. in dull and stereotyped B, high yield NK mutagenesis is merged offspring's periphery of bacterial colonies and is formed transparent circle, can judge to produce NK vigor height by naked eyes according to transparent circle diameter; 5., in dull and stereotyped A and dull and stereotyped B, high yield PQQ bacterium colony and high yield NK bacterium colony are in same position person, is high yield NK and holds concurrently the bafillus natto of PQQ.The high yield NK obtained holds concurrently the bafillus natto called after BN-NKPQQ-RWX-507 of PQQ, is preserved in bean sprout juice strawberry juice solid medium (inclined-plane).
(2) methionine auxotrophicity (Met
-) Lactobacillus casei (LcS-Met
-) seed selection
Lactobacillus casei (Lactobacillus casei Shirota) is carried out nitrosoguanidine mutagenesis, therefrom filters out methionine auxotroph (LcS-Met
-).
LcS-Met
-screening: 1. prepare 2 MRS solid mediums dull and stereotyped, methionine (Met) is allocated into (dull and stereotyped C, Met addition is 10-15mg/L) by one of them, and another is simple MRS solid medium flat board (dull and stereotyped D); 2. after the mutagenic progeny of Lactobacillus casei (Lactobacillus casei Shirota) being coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, makes dull and stereotyped C and dull and stereotyped D photocopy each other flat board; 3. at the same position of dull and stereotyped C and dull and stereotyped D, there is bacterium colony in dull and stereotyped C and bacterium colony does not appear in dull and stereotyped D, or the bacterium colony on dull and stereotyped C is significantly greater than the bacterium colony on dull and stereotyped D, then this bacterium colony methionine auxotroph Lactobacillus casei, called after LcS-Met
-, be preserved in MRS solid medium (inclined-plane).
(3) activation culture of BN-NKPQQ-RWX-507
The BN-NKPQQ-RWX-507 be stored in bean sprout juice strawberry juice solid medium (inclined-plane) is got a ring, is seeded to the activation of bean sprout juice strawberry juice fluid nutrient medium, cultivation temperature 35 DEG C, cultivate end inoculum density and reach 10
9about cfu/mL.
(4) LcS-Met
-activation culture
The LcS-Met in MRS solid medium (inclined-plane) will be stored in
-get a ring, be seeded to MRS fluid nutrient medium 37 DEG C of activation culture, cultivate end inoculum density and reach 10
9about cfu/mL.
(5) fermentation being rich in the strawberry juice of NK and PQQ is standby
By BN-NKPQQ-RWX-507 and the LcS-Met of activation
-mixing, makes the two density ratio in mixed bacteria liquid be 1:5 (1 × 10
8cFM/mL:5 × 10
8cFM/mL), mixed bacteria liquid is with the fermentation medium of 5% inoculum concentration inoculation containing strawberry juice, and 36h is cultivated in 37 DEG C of six layers of gauze sealings, obtains the strawberry juice being rich in NK and PQQ.Containing contained in the fermentation medium of strawberry juice bean sprout juice, tyrosine, glutamic acid and maltose, NK and PQQ is synthesized to BN-NKPQQ-RWX-507 and carry out metabolic regulation, bean sprout juice is conducive to bafillus natto propagation, maltose is conducive to NK synthesis, and PQQ is connected cyclisation with glutamic acid by peptide bond by tyrosine and forms.After fermentation ends, NK vigor 912U/mL in strawberry juice, PQQ content 135ng/mL.The strawberry juice obtained is rich in Nattokinase and PQQ, has the intrinsic flavour of strawberry juice and the rear distinctive local flavor of fermentation.
Chromatography determination PQQ is adopted in the present invention, concrete steps are with reference to " Noji N; Nakamura T; Kitahata N; et al.Simple and sensitive method for pyrroloquinoline quinone (PQQ) analysis in various foods using liquid chromatography/electrospray-lonization tandem mass spectrometry.J Agri Food Chem; 2007,55 (18): 7258-7263. ".
Agarose-fibrinogen plate assay is adopted to measure NK vigor in the present invention.Determination step: by dibbling after filtering fermentation liquor on agarose-fibrin plate, hatches 18h for 37 DEG C, using urokinase as standard items, is equivalent to the unit of activity (U/mL) of urokinase by measuring transparent circle diameter calculating Nattokinase.
Claims (10)
1. there is a preparation method for the fermentation strawberry juice of dietotherapy effect, it is characterized in that, comprise the following steps:
1), nitrosoguanidine mutagenesis is carried out respectively by producing the hold concurrently bafillus natto 10261 of PQQ and bafillus natto 10263 of Nattokinase; Then mutagenic progeny both mixing, carries out Fusion of Cells Secondary Culture, and high flux screening obtains high-yield nattokinase and to hold concurrently the bafillus natto of PQQ, called after bafillus natto BN-NKPQQ-RWX-507;
2), by Lactobacillus casei carry out nitrosoguanidine mutagenesis, therefrom filter out the Lactobacillus casei of methionine auxotroph, called after Lactobacillus casei LcS-Met
-;
3) by bafillus natto BN-NKPQQ-RWX-507 and Lactobacillus casei LcS-Met
-ferment strawberry juice altogether, obtains the strawberry juice being rich in Nattokinase and PQQ.
2. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 1, it is characterized in that, step 1) in, described high flux screening specifically comprises: 1. prepare 2 dull and stereotyped bean sprout juice strawberry juice solid mediums, little mouse-anti PQQ IgG monoclonal antibody PQQ-mAb allocates into by one of them, form dull and stereotyped A, agarose-fibrin is allocated into by another, forms dull and stereotyped B; 2. the mutagenesis of bafillus natto 10261 and bafillus natto 10263 merged after offspring is coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, make dull and stereotyped A and dull and stereotyped B photocopy each other dull and stereotyped; 3. in dull and stereotyped A, the mutagenesis of high yield PQQ is merged offspring's periphery of bacterial colonies and is formed some visual precipitation circle, judges to produce PQQ amount size according to the large I naked eyes of precipitation loop diameter; 4. in dull and stereotyped B, the mutagenesis of high-yield nattokinase is merged offspring's periphery of bacterial colonies and is formed transparent circle, can judge to produce Nattokinase vigor height by naked eyes according to transparent circle diameter; 5., in dull and stereotyped A and dull and stereotyped B, high yield PQQ bacterium colony and high-yield nattokinase bacterium colony are in same position person, is high-yield nattokinase and holds concurrently the bafillus natto of PQQ.
3. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 2, is characterized in that, step 1) in, described dull and stereotyped bean sprout juice strawberry juice solid medium, in 1L, is made up of the component of following amount:
4. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 1, it is characterized in that, step 2) in, the described Lactobacillus casei therefrom filtering out methionine auxotroph, specifically comprise: 1. prepare 2 dull and stereotyped MRS solid mediums, methionine is allocated into by one of them, is dull and stereotyped C, another is that simple MRS solid medium is dull and stereotyped, is dull and stereotyped D; 2. after the Lactobacillus casei after mutagenesis being coated with one of them flat board, the photocopy of reprocess fibre element film is dull and stereotyped to another, makes dull and stereotyped C and dull and stereotyped D photocopy each other flat board; 3. at the same position of dull and stereotyped C and dull and stereotyped D, there is bacterium colony in dull and stereotyped C and bacterium colony does not appear in dull and stereotyped D, or the bacterium colony on dull and stereotyped C is significantly greater than the bacterium colony on dull and stereotyped D, then this bacterium colony is methionine auxotroph Lactobacillus casei.
5. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 4, is characterized in that, step 2) in, described dull and stereotyped MRS solid medium, in 1L, is made up of the component of following amount:
The pH value of this MRS solid medium remains on 6.2 ~ 6.4.
6. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 1, is characterized in that, step 3) in, before common fermentation, by bafillus natto BN-NKPQQ-RWX-507 and Lactobacillus casei LcS-Met
-carry out activation culture respectively, bafillus natto BN-NKPQQ-RWX-507 carries out activation culture in bean sprout juice strawberry juice fluid nutrient medium, and cultivation temperature is 34 ~ 36 DEG C, Lactobacillus casei LcS-Met
-in MRS fluid nutrient medium, carry out activation culture, cultivation temperature is 36 ~ 38 DEG C.
7. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 6, is characterized in that, step 3) in, described bean sprout juice strawberry juice fluid nutrient medium, in 1L, is made up of the component of following amount:
Strawberry juice 100 ~ 150mL;
Sucrose 4.0 ~ 6.0g;
Bean sprout juice surplus;
Described MRS fluid nutrient medium, in 1L, is made up of the component of following amount:
The pH value of this MRS fluid nutrient medium remains on 6.2 ~ 6.4.
8. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 1, is characterized in that, step 3) in, by bafillus natto BN-NKPQQ-RWX-507 and Lactobacillus casei LcS-Met
-ferment strawberry juice altogether, specifically comprises: by the bafillus natto BN-NKPQQ-RWX-507 after activation and Lactobacillus casei LcS-Met
-mixing, forms mixed bacteria liquid, mixed bacteria liquid is seeded to the fermentation medium containing strawberry juice, and gauze sealing obtains the strawberry juice being rich in Nattokinase and PQQ after cultivating.
9. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 8, is characterized in that, step 3) in, the described fermentation medium containing strawberry juice, in 1L, is made up of the component of following amount:
10. the preparation method with the fermentation strawberry juice of dietotherapy effect according to claim 1, is characterized in that, step 3) in, the preparation of described strawberry juice comprises: add strawberry in water, is milled into juice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410750887.6A CN104432322A (en) | 2014-12-10 | 2014-12-10 | Method for preparing fermented strawberry juice with therapeutic efficacy |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410750887.6A CN104432322A (en) | 2014-12-10 | 2014-12-10 | Method for preparing fermented strawberry juice with therapeutic efficacy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104432322A true CN104432322A (en) | 2015-03-25 |
Family
ID=52879669
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410750887.6A Pending CN104432322A (en) | 2014-12-10 | 2014-12-10 | Method for preparing fermented strawberry juice with therapeutic efficacy |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104432322A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100919213B1 (en) * | 2007-10-19 | 2009-09-28 | 전라북도 고창군 | Function-related fermentation raw materials using the composition which mixed chlorella in Rubus coreanus and Method to produce thereof |
| CN103740695A (en) * | 2013-12-20 | 2014-04-23 | 浙江大学 | Method for screening lactobacilli producing pyrroloquinoline quinone and preparation method of pyrroloquinoline quinone |
-
2014
- 2014-12-10 CN CN201410750887.6A patent/CN104432322A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100919213B1 (en) * | 2007-10-19 | 2009-09-28 | 전라북도 고창군 | Function-related fermentation raw materials using the composition which mixed chlorella in Rubus coreanus and Method to produce thereof |
| CN103740695A (en) * | 2013-12-20 | 2014-04-23 | 浙江大学 | Method for screening lactobacilli producing pyrroloquinoline quinone and preparation method of pyrroloquinoline quinone |
Non-Patent Citations (3)
| Title |
|---|
| 徐薇薇，林永华，阮晖，等: "纳豆芽孢杆菌与干酪乳杆菌共发酵制备富含纳豆激酶和吡咯喹啉醌的凝固型酸豆乳", 《中国食品科学技术学会第十一届年会论文摘要集》 * |
| 沙维: "不同方法诱变T_3纳豆激酶菌株的研究", 《中国优秀硕士学位论文全文数据库（电子期刊）》 * |
| 赵人俊，张益棻，郑幼霞: "NTG对庆丰链霉菌诱发产生营养缺陷型突变体的研究", 《遗传》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104489831A (en) | Method for preparing food therapy brown rice juice by co-fermenting bacillus natto and lactic acid bacteria | |
| CN104473256A (en) | Preparation method of tomato juice for dietary therapy | |
| CN104522586A (en) | Making method of dietary therapy fermented leaf mustard | |
| CN104382155A (en) | Preparation method of fermented pineapple juice | |
| CN104432326A (en) | Preparation method of dietary therapeutic fermented bayberry juice | |
| CN104472685A (en) | Method of preparing yoghourt rich in nattokinase and pyrroloquinoline quinine through breeding bacillus natto and lactobacillus casei and co-fermentation | |
| CN104430853A (en) | Method for preparing fermented goat milk rich in pyrroloquinoline quinine and nattokinase by virtue of breeding and co-fermentation of bacillus natto and lactobacillus casei | |
| CN104473255A (en) | Preparation method of fermented lycium ruthenicum mill juice for dietary therapy | |
| CN104431853A (en) | Method for producing dietary therapy brassica oleracea by virtue of co-fermentation of bacillus natto and lactobacillus | |
| CN104522513A (en) | Method for preparing fermented rice cake from bacillus natto and lactic acid bacteria | |
| CN104432379A (en) | Preparation method of diet-fermented purple rice juice rich in pyrroloquinoline quinone and nattokinase | |
| CN104397620A (en) | Method for breeding bacillus natto and lactobacillus casei shirota to ferment LactucapsativapL.var.asparaginapBailey | |
| CN104397805A (en) | Method for diet therapy grape juice through co-fermentation of bred bacillus natto and lactobacillus casei | |
| CN104473264A (en) | Production method of apple juice rich in dietary therapy components | |
| CN104522181A (en) | Method for preparing pea milk through symbiotic culture of bacillus natto and lactobacillus casei | |
| CN104431874A (en) | Preparation method of diet-fermented potato juice rich in nattokinase and pyrroloquinoline quinone | |
| CN104522180A (en) | Method for preparing dietary therapy white kidney bean milk through co-fermentation of bacillus natto and lactobacillus casei | |
| CN104430910A (en) | Preparation method of chickpea soya-bean milk rich in nattokinase and pyrroloquinoline quinone | |
| CN104397196A (en) | Preparation method of sour soybean milk rich in natto kinase and pyrroloquinoline quinone | |
| CN104489116A (en) | Method for preparing peanut milk through co-fermentation of selected bacillus natto and lactobacillus casei | |
| CN104522774A (en) | Preparation method of food-therapy fermented sweet potato juice rich in nattokinase and pyrroloquinoline quinone | |
| CN104432324A (en) | Preparation method of diet-fermented konjak juice rich in pyrroloquinoline quinone and nattokinase | |
| CN104432322A (en) | Method for preparing fermented strawberry juice with therapeutic efficacy | |
| CN104381465A (en) | Method for preparing red kidney bean milk rich in nattokinase and pyrroloquinoline quinone | |
| CN104522773A (en) | Production method of fermented mango juice containing rich nattokinase and pyrroloquinoline quinine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
| RJ01 | Rejection of invention patent application after publication |